Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HERZ
6026
Herzfeld Credit Income Fund
HERZ
$32.6M
| $23K | ﹤0.01% |
681
-7
| -1% | -$221 |
|
6027
Design Therapeutics
DSGN
$928M
| $23K | ﹤0.01% |
3,574
+1,508
| +73% | +$9.23K |
|
6028
Erasca
ERAS
$6.43B
| $23K | ﹤0.01% |
8,418
+4,374
| +108% | +$12.5K |
|
6029
Gerdau
GGB
$9.3B
| $23K | ﹤0.01% |
5,294
+3,291
| +164% | +$13.7K |
|
6030
Hagerty
HGTY
$1.32B
| $23K | ﹤0.01% |
2,418
-100,025
| -98% | -$922K |
|
|
HSHP
6031
Himalaya Shipping
HSHP
$760M
| $23K | ﹤0.01% |
+4,104
| New | +$23.3K |
|
6032
Information Services Group
III
$250M
| $23K | ﹤0.01% |
4,408
+2,231
| +102% | +$11.6K |
|
6033
iRadimed
IRMD
$1.11B
| $23K | ﹤0.01% |
487
-456
| -48% | -$20.6K |
|
6034
KRONOS Worldwide
KRO
$975M
| $23K | ﹤0.01% |
2,613
+1,025
| +65% | +$9.04K |
|
|
NEWP
6035
New Pacific Metals
NEWP
$1.27B
| $23K | ﹤0.01% |
10,373
-3,894
| -27% | -$9.53K |
|
6036
Pulse Biosciences
PLSE
$3.18B
| $23K | ﹤0.01% |
3,136
-1,431
| -31% | -$9.14K |
|
|
PPTA
6037
Perpetua Resources
PPTA
$3.16B
| $23K | ﹤0.01% |
6,119
-3,968
| -39% | -$18.3K |
|
6038
Red Violet
RDVT
$1.12B
| $23K | ﹤0.01% |
1,142
+513
| +82% | +$9.58K |
|
6039
Fidelity Fundamental Large Cap Growth ETF
FFLG
$624M
| $23K | ﹤0.01% |
1,381
+381
| +38% | +$5.87K |
|
|
BSMO
6040
DELISTED
Invesco BulletShares 2024 Municipal Bond ETF
BSMO
| $23K | ﹤0.01% |
938
-3,146
| -77% | -$77.9K |
|
|
BHIL
6041
DELISTED
Benson Hill, Inc.
BHIL
| $23K | ﹤0.01% |
516
+241
| +88% | +$10.3K |
|
|
AZRE
6042
DELISTED
Azure Power Global Limited
AZRE
| $23K | ﹤0.01% |
12,922
-51,321
| -80% | -$112K |
|
|
WMC
6043
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $23K | ﹤0.01% |
2,566
+2,541
| +10,164% | +$22.1K |
|
6044
Arbutus Biopharma
ABUS
$924M
| $22K | ﹤0.01% |
9,765
-82,014
| -89% | -$213K |
|
6045
ADC Therapeutics
ADCT
$128M
| $22K | ﹤0.01% |
10,124
+3,121
| +45% | +$7.02K |
|
6046
Aptus Behavioral Momentum ETF
ADME
$308M
| $22K | ﹤0.01% |
600
| – | – |
|
6047
Aqua Metals
AQMS
$9.99M
| $22K | ﹤0.01% |
96
+10
| +12% | +$2.18K |
|
|
ATXS
6048
DELISTED
Astria Therapeutics
ATXS
| $22K | ﹤0.01% |
+2,635
| New | +$30.4K |
|
6049
Braskem
BAK
$777M
| $22K | ﹤0.01% |
1,923
+1,391
| +261% | +$13.2K |
|
|
EDF
6050
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$167M
| $22K | ﹤0.01% |
4,960
+2,585
| +109% | +$11.1K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.